JESSICA WENZEL: Open Payments
NPI 1649719568 · LAMBERTVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 25 payments from 12 companies in 2025. Trend: 2023 $199 · 2024 $333 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $100 |
| Novo Nordisk Inc | 4 | $77 |
| PFIZER INC. | 2 | $46 |
| Exact Sciences Corporation | 2 | $45 |
| Lilly USA, LLC | 2 | $45 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| Esperion Therapeutics, Inc. | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Astellas Pharma US Inc | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
Products named: AIRSUPRA, Cologuard Collection Kit, Ozempic, GEMTESA, NEXLETOL, ZEPBOUND, PREVNAR 20, Veozah.
Industry payments across MI — which companies pay providers there.
